Monopar Therapeutics (MNPR) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 4, 2026.
- Filings shown
- 15
- Open-market buys
- 0
- Open-market sells
- 25
Counts cover the 15 most recent Form 4 filings Tradune holds for MNPR (filed Jun 30 – Nov 4, 2026); the score below covers only the trailing 90 days (0 buys, 25 sells). SEC EDGAR Form 4 filings for MNPR last checked Nov 22, 2026, 09:00 UTC; the latest MNPR filing Tradune holds was filed Nov 4, 2026. This is not guaranteed to be the complete record — see MNPR's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for MNPR filed Aug 27 – Nov 4, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
25 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 25 sales· 51,921 sh
- checkbox disclosed
- On filings with the box not checked
- 0 sales· 0 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Kim R. TsuchimotoDirector | 0 | 10 | — | 8,180 | −$745,628 |
| Raymond AndersonDirector | 0 | 7 | — | 6,284 | −$566,582 |
| Chandler RobinsonChief Executive Officer | 0 | 4 | — | 29,056 | −$2,556,851 |
| Christopher M. StarrDirector | 0 | 3 | — | 8,400 | −$659,387 |
| Patrice RiouxInsider | 0 | 1 | — | 1 | −$111 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at MNPR
No open-market insider purchases (Form 4 code P) were reported for MNPR between Jun 30, 2026 and Nov 4, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 2,035 | $14.00 | 2,891 | +238% | Nov 4, 2026 |
| Open-market sale 10b5-1 box checked | 1,295 | $70.75 | 1,596 | −45% | Nov 4, 2026 |
| Open-market sale 10b5-1 box checked | 996 | $71.35 | 600 | −62% | Nov 4, 2026 |
| Open-market sale 10b5-1 box checked | 600 | $72.21 | 0 | −100% | Nov 4, 2026 |
| Option exercise | 856 | $30.00 | 856 | — | Nov 4, 2026 |
| Option exercise Stock Option | 856 | — | — | — | Nov 4, 2026 |
| Option exercise Stock Option | 2,035 | — | — | — | Nov 4, 2026 |
| Option exercise | 1,199 | $30.00 | 1,199 | — | Nov 2, 2026 |
| Open-market sale 10b5-1 box checked | 1,199 | $70.10 | 0 | −100% | Nov 2, 2026 |
| Option exercise Stock Option | 1,199 | — | — | — | Nov 2, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 600 | $67.06 | 7,075 | −7.8% | Nov 2, 2026 |
| Open-market sale 10b5-1 box checked | 200 | $68.68 | 6,875 | −2.8% | Nov 2, 2026 |
| Open-market sale 10b5-1 box checked | 1,502 | $70.04 | 5,373 | −22% | Nov 2, 2026 |
| Option exercise Stock Option | 1,402 | — | — | — | Nov 2, 2026 |
| Option exercise Stock Option | 1,740 | — | — | — | Nov 2, 2026 |
| Option exercise | 1,402 | $30.00 | 6,775 | +26% | Nov 2, 2026 |
| Option exercise | 1,740 | $30.00 | 8,515 | +26% | Nov 2, 2026 |
| Open-market sale 10b5-1 box checked | 840 | $66.16 | 7,675 | −9.9% | Nov 2, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 597 | $92.59 | 104,127 | −0.6% | Oct 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Stock Option | 8,400 | — | — | — | Oct 1, 2026 |
| Open-market sale 10b5-1 box checked | 799 | $79.67 | 5,173 | −13% | Oct 1, 2026 |
| Open-market sale 10b5-1 box checked | 2,970 | $78.82 | 5,972 | −33% | Oct 1, 2026 |
| Open-market sale 10b5-1 box checked | 4,631 | $78.09 | 8,942 | −34% | Oct 1, 2026 |
| Option exercise | 8,400 | $0.01 | 13,573 | +162% | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 4,384 | — | 59,998 | +7.9% | Sep 30, 2026 |
| Tax withholding | 1,944 | $79.67 | 58,054 | −3.2% | Sep 30, 2026 |
| Option exercise Restricted Stock Unit | 4,384 | — | — | — | Sep 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 9,801 | — | 109,068 | +9.9% | Sep 30, 2026 |
| Tax withholding | 4,344 | $79.67 | 104,724 | −4.0% | Sep 30, 2026 |
| Option exercise Restricted Stock Unit | 9,801 | — | — | — | Sep 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 614 | — | 2,835 | +28% | Sep 30, 2026 |
| Tax withholding | 180 | $79.67 | 2,655 | −6.3% | Sep 30, 2026 |
| Option exercise Restricted Stock Unit | 614 | — | — | — | Sep 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Stock Option | 14,056 | — | — | — | Sep 24, 2026 |
| Option exercise Stock Option | 15,000 | — | — | — | Sep 24, 2026 |
| Option exercise | 14,056 | $30.00 | 113,323 | +14% | Sep 24, 2026 |
| Option exercise | 15,000 | $14.00 | 128,323 | +13% | Sep 24, 2026 |
| Open-market sale 10b5-1 box checked | 10,450 | $87.15 | 117,873 | −8.1% | Sep 24, 2026 |
| Open-market sale 10b5-1 box checked | 9,638 | $87.96 | 108,235 | −8.2% | Sep 24, 2026 |
| Open-market sale 10b5-1 box checked | 8,368 | $88.97 | 99,867 | −7.7% | Sep 24, 2026 |
| Open-market sale 10b5-1 box checked | 600 | $89.79 | 99,267 | −0.6% | Sep 24, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 485 | $108.83 | 3,605 | −12% | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 700 | $110.65 | 2,290 | −23% | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 1,098 | $111.84 | 1,192 | −48% | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 602 | $112.93 | 590 | −51% | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 590 | $113.84 | 0 | −100% | Aug 26, 2026 |
| Option exercise Stock Option | 2,055 | — | — | — | Aug 26, 2026 |
| Option exercise Stock Option | 2,035 | — | — | — | Aug 26, 2026 |
| Option exercise | 2,055 | $30.00 | 2,055 | — | Aug 26, 2026 |
| Option exercise | 2,035 | $14.00 | 4,090 | +99% | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 615 | $109.56 | 2,990 | −17% | Aug 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 1,740 | $30.00 | 8,515 | +26% | Aug 25, 2026 |
| Open-market sale 10b5-1 box checked | 646 | $111.07 | 7,175 | −8.3% | Aug 25, 2026 |
| Open-market sale 10b5-1 box checked | 1,802 | $113.05 | 5,373 | −25% | Aug 25, 2026 |
| Option exercise Stock Option | 1,402 | — | — | — | Aug 25, 2026 |
| Option exercise Stock Option | 1,740 | — | — | — | Aug 25, 2026 |
| Option exercise | 1,402 | $30.00 | 6,775 | +26% | Aug 25, 2026 |
| Open-market sale 10b5-1 box checked | 694 | $110.04 | 7,821 | −8.2% | Aug 25, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Stock Option | 1,380 | — | — | — | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 1 | $111.26 | 5,065 | −0.0% | Aug 26, 2026 |
| Option exercise | 1,380 | $0.01 | 5,066 | +37% | Aug 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 1,228 | — | 2,728 | +82% | Jun 30, 2026 |
| Tax withholding | 507 | $92.59 | 2,221 | −19% | Jun 30, 2026 |
| Option exercise Restricted Stock Unit | 1,228 | — | — | — | Jun 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Unit | 12,873 | — | — | — | Jun 30, 2026 |
| Tax withholding | 4,084 | $92.59 | 99,267 | −4.0% | Jun 30, 2026 |
| Option exercise | 12,873 | — | 103,351 | +14% | Jun 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Unit | 5,254 | — | — | — | Jun 30, 2026 |
| Tax withholding | 2,309 | $92.59 | 55,614 | −4.0% | Jun 30, 2026 |
| Option exercise | 5,254 | — | 57,923 | +10.0% | Jun 30, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,284 | — | — | — | Jun 26, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to MNPR's (Nov 4, 2026).
Frequently asked about MNPR insider activity
How many insiders bought MNPR stock in these Form 4 filings?
No open-market purchases (Form 4 code P) of MNPR shares were reported by Monopar Therapeutics insiders between Jun 30, 2026 and Nov 4, 2026. The 15 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.
Who filed the most recent Form 4 for MNPR?
The most recent Form 4 on this page was filed by Raymond Anderson (Director) on Nov 4, 2026, reporting 8 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market MNPR insider sale shown?
The largest open-market sale among the filings shown was 10,450 MNPR shares at $87.15 (about $910,718) by Chandler Robinson (Chief Executive Officer) on Sep 24, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for MNPR — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.